Regulus Therapeutics Inc. (RGLS)

Regulus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	49.46	38.53	23.77	24.23	60.38	31.09
Short-Term Investments	15.91	37.25	-	14.93	-	-
Cash & Short-Term Investments	65.37	75.78	23.77	39.16	60.38	31.09
Cash Growth	-32.99%	218.83%	-39.31%	-35.15%	94.24%	-8.89%
Receivables	-	-	-	-	-	0.5
Inventory	3.47	3.49	3.01	3.01	3.01	3.31
Prepaid Expenses	2.79	3.02	1.34	1.85	1.78	1.83
Restricted Cash	0.06	0.06	0.06	0.06	0.06	-
Total Current Assets	71.69	82.35	28.18	44.08	65.24	36.73
Property, Plant & Equipment	3.11	1.81	2.54	2.58	2.85	0.73
Other Intangible Assets	0.02	0.03	0.03	0.06	0.08	0.13
Other Long-Term Assets	-	-	-	-	0.29	0.02
Total Assets	74.83	84.18	30.75	46.72	68.45	37.6
Accounts Payable	0.2	0.95	0.2	0.18	0.29	0.54
Accrued Expenses	3.4	5.4	4.59	4.42	3.65	3.42
Current Portion of Long-Term Debt	-	-	1.33	4.51	-	4.65
Current Portion of Leases	-	0.78	0.71	0.65	0.59	0.47
Other Current Liabilities	0.8	0.37	1.67	1.9	0.71	2.5
Total Current Liabilities	4.4	7.5	8.51	11.66	5.23	11.58
Long-Term Debt	-	-	-	-	4.67	-
Long-Term Leases	1.4	0.27	1.06	1.77	2.42	-
Other Long-Term Liabilities	-	-	-	-	1.18	-
Total Liabilities	5.8	7.77	9.56	13.43	13.5	11.58
Common Stock	0.07	0.07	0.02	0.02	0.02	0.07
Additional Paid-In Capital	638.15	635.86	534.38	516.46	509.79	453
Retained Earnings	-569.21	-559.57	-513.21	-483.18	-454.85	-427.05
Comprehensive Income & Other	0.01	0.05	-	-0.01	-	-
Total Common Equity	69.02	76.4	21.18	33.29	54.95	26.02
Shareholders' Equity	69.03	76.41	21.19	33.29	54.96	26.03
Total Liabilities & Equity	74.83	84.18	30.75	46.72	68.45	37.6
Total Debt	1.4	1.06	3.1	6.93	7.68	5.13
Net Cash (Debt)	63.97	74.72	20.67	32.23	52.7	25.96
Net Cash Growth	-32.96%	261.59%	-35.89%	-38.84%	103.00%	41.26%
Net Cash Per Share	0.97	1.33	1.09	2.11	6.15	7.42
Filing Date Shares Outstanding	69.23	66.24	65.47	16.84	14.6	7.25
Total Common Shares Outstanding	66.28	65.5	20.22	16.84	14.6	6.74
Working Capital	67.3	74.85	19.67	32.42	60.01	25.15
Book Value Per Share	1.04	1.17	1.05	1.98	3.76	3.86
Tangible Book Value	69	76.38	21.15	33.22	54.87	25.9
Tangible Book Value Per Share	1.04	1.17	1.05	1.97	3.76	3.84
Machinery	-	5.41	5.07	4.84	4.48	5.25
Construction In Progress	-	-	0.13	-	-	-
Leasehold Improvements	-	0.12	0.12	0.12	0.12	0.08

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q